0001246360-14-004791.txt : 20141230 0001246360-14-004791.hdr.sgml : 20141230 20141230164909 ACCESSION NUMBER: 0001246360-14-004791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141229 FILED AS OF DATE: 20141230 DATE AS OF CHANGE: 20141230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Heberlig Chris CENTRAL INDEX KEY: 0001532217 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 141316461 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 form.xml PRIMARY DOCUMENT X0306 4 2014-12-29 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532217 Heberlig Chris 33 HAYDEN AVE LEXINGTON MA 02421 false true false false Group Vice President, Finance Common Stock 2014-12-29 4 M false 1100 1.7 A 1404 D Common Stock 2014-12-29 4 M false 5000 23 A 6404 D Common Stock 2014-12-29 4 S false 1800 89.9 D 4604 D Common Stock 2014-12-29 4 S false 2844 91.34 D 1760 D Common Stock 2014-12-29 4 S false 1156 92.1 D 604 D Common Stock 2014-12-29 4 S false 300 93.04 D 304 D Stock Option (Right to Buy) 1.7 2014-12-29 4 M false 1100 0 D 2021-05-25 Common Stock 1100 838 D Stock Option (Right to Buy) 23 2014-12-29 4 M false 5000 0 D 2021-12-20 Common Stock 5000 5000 D The stock option exercise and sale of shares of the Company's common stock (the "Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 3, 2014. The Stock Option granted the reporting person an option to purchase 6,188 Shares. 25% of such Shares vested and became exercisable on 05/25/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. The Stock Option granted the reporting person an option to purchase 15,000 Shares. 25% of such Shares vested and became exercisable on 12/20/2012, and 1/36 of the remainder of such Shares vest and become exercisable monthly thereafter. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $89.65 to $90.47. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $90.82 to $91.84. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $91.88 to $92.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.92 to $93.20. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. /s/ Chris Heberlig 2014-12-30